• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫和代谢相关基因特征分析揭示了肝细胞癌的预后和免疫微环境。

Immune- and metabolism-related gene signature analysis uncovers the prognostic and immune microenvironments of hepatocellular carcinoma.

机构信息

Liver Transplantation Center, General Surgery, Huashan Hospital, Fudan University, Shanghai, China.

Institute of Organ Transplantation, Fudan University, Shanghai, China.

出版信息

J Cancer Res Clin Oncol. 2024 Jun 19;150(6):311. doi: 10.1007/s00432-024-05849-5.

DOI:10.1007/s00432-024-05849-5
PMID:38896142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11186947/
Abstract

BACKGROUND

Metabolic reprogramming is an emerging hallmark that influences the tumour microenvironment (TME) by regulating the behavior of cancer cells and immune cells. The relationship between metabolism and immunity remains elusive. The purpose of this study was to explore the predictive value of immune- and metabolism-related genes in hepatocellular carcinoma (HCC) and their intricate interplay with TME.

METHODS

We established the immune- and metabolism-related signature (IMRPS) based on the LIHC cohort from The Cancer Genome Atlas (TCGA) dataset. Kaplan-Meier analysis, receiver operating characteristic (ROC) curve analysis and Cox regression analysis confirmed the prognostic value of IMRPS. We investigated differences in immune cell infiltration, clinical features, and therapeutic response between risk groups. The quantitative real-time PCR (qPCR) was used to confirm the expression of signature genes. Immunohistochemical staining was performed to evaluate immune infiltration features in HCC tissue samples. We conducted cell experiments including gene knockout, cell counting kit-8 (CCK-8), and flow cytometry to explore the role of the IMRPS key gene UCK2 in HCC. RNA-seq was used to further investigate the potential underlying mechanism involved.

RESULTS

The IMRPS, composed of four genes, SMS, UCK2, PFKFB4 and MAPT, exhibited significant correlations with survival, immune cell infiltration, clinical features, immune checkpoints and therapeutic response. The IMRPS was shown to be an excellent predictor of HCC prognosis. It could stratify patients appropriately and characterize the TME accurately. The high-risk HCC group exhibited an immunosuppressive microenvironment with abundant M-like macrophage infiltration, which was confirmed by the immunohistochemistry results. The results of qPCR revealed that the expression of signature genes in 20 HCC tissues was significantly greater than that in adjacent normal tissues. After the key gene UCK2 was knocked out, the proliferation of the Huh7 cell line was significantly inhibited, and monocyte-derived macrophages polarized towards an M1-like phenotype in the coculture system. RNA-seq and GSEA suggested that the phenotypes were closely related to the negative regulation of growth and regulation of macrophage chemotaxis.

CONCLUSIONS

This study established a new IMRS for the accurate prediction of patient prognosis and the TME, which is also helpful for identifying new targets for the treatment of HCC.

摘要

背景

代谢重编程是一个新兴的标志,通过调节癌细胞和免疫细胞的行为来影响肿瘤微环境(TME)。代谢与免疫之间的关系仍然难以捉摸。本研究旨在探讨肝癌(HCC)中免疫和代谢相关基因的预测价值及其与 TME 的复杂相互作用。

方法

我们基于 TCGA 数据集的 LIHC 队列建立了免疫和代谢相关特征(IMRPS)。Kaplan-Meier 分析、接收者操作特征(ROC)曲线分析和 Cox 回归分析证实了 IMRPS 的预后价值。我们研究了风险组之间免疫细胞浸润、临床特征和治疗反应的差异。定量实时 PCR(qPCR)用于确认特征基因的表达。免疫组织化学染色用于评估 HCC 组织样本中的免疫浸润特征。我们进行了细胞实验,包括基因敲除、细胞计数试剂盒-8(CCK-8)和流式细胞术,以探讨 HCC 中 IMRPS 关键基因 UCK2 的作用。RNA-seq 用于进一步研究潜在的潜在机制。

结果

由四个基因 SMS、UCK2、PFKFB4 和 MAPT 组成的 IMRPS 与生存、免疫细胞浸润、临床特征、免疫检查点和治疗反应显著相关。IMRPS 是 HCC 预后的极佳预测指标。它可以适当地对患者进行分层,并准确地描述 TME。高风险 HCC 组表现出免疫抑制的微环境,其中富含 M 样巨噬细胞浸润,免疫组织化学结果证实了这一点。qPCR 结果显示,20 例 HCC 组织中特征基因的表达明显高于相邻正常组织。关键基因 UCK2 敲除后,Huh7 细胞系的增殖明显受到抑制,在共培养系统中单核细胞衍生的巨噬细胞向 M1 样表型极化。RNA-seq 和 GSEA 表明表型与生长的负调节和巨噬细胞趋化性的调节密切相关。

结论

本研究建立了一种新的免疫代谢风险评分(IMRS),用于准确预测患者预后和 TME,这也有助于确定 HCC 治疗的新靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79c/11186947/d9be6227b098/432_2024_5849_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79c/11186947/c5edbb0a60c9/432_2024_5849_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79c/11186947/6153a6a6c03a/432_2024_5849_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79c/11186947/c5c1c0513b41/432_2024_5849_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79c/11186947/1f8baf248716/432_2024_5849_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79c/11186947/ec2bad2a17de/432_2024_5849_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79c/11186947/08669ff7a871/432_2024_5849_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79c/11186947/fc341ca68171/432_2024_5849_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79c/11186947/d9be6227b098/432_2024_5849_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79c/11186947/c5edbb0a60c9/432_2024_5849_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79c/11186947/6153a6a6c03a/432_2024_5849_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79c/11186947/c5c1c0513b41/432_2024_5849_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79c/11186947/1f8baf248716/432_2024_5849_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79c/11186947/ec2bad2a17de/432_2024_5849_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79c/11186947/08669ff7a871/432_2024_5849_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79c/11186947/fc341ca68171/432_2024_5849_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79c/11186947/d9be6227b098/432_2024_5849_Fig8_HTML.jpg

相似文献

1
Immune- and metabolism-related gene signature analysis uncovers the prognostic and immune microenvironments of hepatocellular carcinoma.免疫和代谢相关基因特征分析揭示了肝细胞癌的预后和免疫微环境。
J Cancer Res Clin Oncol. 2024 Jun 19;150(6):311. doi: 10.1007/s00432-024-05849-5.
2
Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies.基于生物信息学和机器学习策略的基于干性分类器的肝细胞癌预后和免疫治疗反应的预测价值。
Front Immunol. 2024 Apr 17;15:1244392. doi: 10.3389/fimmu.2024.1244392. eCollection 2024.
3
A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.铜死亡相关长链非编码 RNA 风险模型预测肝细胞癌患者的预后和免疫治疗疗效。
Biochem Genet. 2024 Jun;62(3):2332-2351. doi: 10.1007/s10528-023-10539-x. Epub 2023 Oct 29.
4
Histamine-related genes participate in the establishment of an immunosuppressive microenvironment and impact the immunotherapy response in hepatocellular carcinoma.与组胺相关的基因参与了免疫抑制微环境的建立,并影响了肝细胞癌的免疫治疗反应。
Clin Exp Med. 2024 Jun 17;24(1):129. doi: 10.1007/s10238-024-01399-9.
5
Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.基于肝癌微环境构建风险评分预后模型。
World J Gastroenterol. 2020 Jan 14;26(2):134-153. doi: 10.3748/wjg.v26.i2.134.
6
Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.鉴定免疫浸润相关基因作为肝细胞癌的预后指标。
BMC Cancer. 2022 May 5;22(1):496. doi: 10.1186/s12885-022-09587-0.
7
Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification.基于生物信息学分析和实验验证的肝细胞癌 PANoptosis 相关亚型鉴定、预后特征构建和肿瘤微环境分析。
Front Immunol. 2024 Apr 29;15:1323199. doi: 10.3389/fimmu.2024.1323199. eCollection 2024.
8
A Novel RNA Methylation-Related Prognostic Signature and its Tumor Microenvironment Characterization in Hepatocellular Carcinoma.新型 RNA 甲基化相关预后标志物及其在肝细胞癌中的肿瘤微环境特征。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241276895. doi: 10.1177/15330338241276895.
9
Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma.超重/肥胖相关的转录组特征与肝细胞癌的临床结局、免疫微环境和治疗反应相关。
Front Endocrinol (Lausanne). 2023 Jan 12;13:1061091. doi: 10.3389/fendo.2022.1061091. eCollection 2022.
10
Integrated analysis reveals an aspartate metabolism-related gene signature for predicting the overall survival in patients with hepatocellular carcinoma.综合分析揭示了天冬氨酸代谢相关基因特征,可用于预测肝细胞癌患者的总生存期。
Clin Transl Oncol. 2024 Sep;26(9):2181-2197. doi: 10.1007/s12094-024-03431-6. Epub 2024 Mar 12.

引用本文的文献

1
USP5 motivates immunosuppressive microenvironment in multiple myeloma by activating STAT2-PFKFB4-mediated glycolysis.USP5通过激活STAT2-PFKFB4介导的糖酵解来激发多发性骨髓瘤中的免疫抑制微环境。
Cancer Immunol Immunother. 2025 Apr 24;74(6):180. doi: 10.1007/s00262-025-04031-1.
2
Uridine-cytidine kinase 2 is correlated with immune, DNA damage repair and promotion of cancer stemness in pan-cancer.尿苷-胞苷激酶2与泛癌中的免疫、DNA损伤修复及癌症干性促进相关。
Front Oncol. 2025 Jan 27;15:1503300. doi: 10.3389/fonc.2025.1503300. eCollection 2025.

本文引用的文献

1
Targeting lipid metabolism in cancer metastasis.靶向肿瘤转移中的脂质代谢。
Biochim Biophys Acta Rev Cancer. 2024 Jan;1879(1):189051. doi: 10.1016/j.bbcan.2023.189051. Epub 2023 Dec 13.
2
TIGIT blockade repolarizes AML-associated TIGIT M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis.TIGIT 阻断使 AML 相关的 TIGIT M2 巨噬细胞重新极化至 M1 表型,并增加 CD47 介导的吞噬作用。
J Immunother Cancer. 2022 Dec;10(12). doi: 10.1136/jitc-2022-004794.
3
Targeting uridine-cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma.
靶向尿苷-胞苷激酶 2 通过双重机制诱导细胞周期停滞,并能提高肝癌的免疫反应。
Cell Mol Biol Lett. 2022 Nov 26;27(1):105. doi: 10.1186/s11658-022-00403-y.
4
Evolving therapeutic landscape of advanced hepatocellular carcinoma.晚期肝细胞癌不断演变的治疗格局。
Nat Rev Gastroenterol Hepatol. 2023 Apr;20(4):203-222. doi: 10.1038/s41575-022-00704-9. Epub 2022 Nov 11.
5
Genomic and transcriptomic profiling indicates the prognosis significance of mutational signature for TMB-high subtype in Chinese patients with gastric cancer.基因组和转录组谱分析表明,突变特征对于中国胃癌 TMB 高亚型患者的预后具有重要意义。
J Adv Res. 2023 Sep;51:121-134. doi: 10.1016/j.jare.2022.10.019. Epub 2022 Nov 10.
6
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities.代谢重编程与癌症表观遗传学的串扰:机制与治疗机会的更新。
Cancer Commun (Lond). 2022 Nov;42(11):1049-1082. doi: 10.1002/cac2.12374. Epub 2022 Oct 20.
7
Crosstalk among mA RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application.m6A RNA 甲基化、缺氧和 TME 代谢重编程之间的串扰:从免疫抑制微环境到临床应用。
J Hematol Oncol. 2022 Jul 6;15(1):84. doi: 10.1186/s13045-022-01304-5.
8
A common framework of monocyte-derived macrophage activation.单核细胞衍生的巨噬细胞激活的通用框架。
Sci Immunol. 2022 Apr 15;7(70):eabl7482. doi: 10.1126/sciimmunol.abl7482.
9
The predictive efficacy of tumor mutation burden in immunotherapy across multiple cancer types: A meta-analysis and bioinformatics analysis.肿瘤突变负荷在多种癌症类型免疫治疗中的预测疗效:一项荟萃分析和生物信息学分析
Transl Oncol. 2022 Jun;20:101375. doi: 10.1016/j.tranon.2022.101375. Epub 2022 Mar 23.
10
Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis.SIRT5 缺失促进胆汁酸诱导的免疫抑制微环境和肝癌发生。
J Hepatol. 2022 Aug;77(2):453-466. doi: 10.1016/j.jhep.2022.02.030. Epub 2022 Mar 12.